Document is current
Any future updates will be listed below
-
Authors
Rivera-Soto, Ricardo http://orcid.org/0000-0003-2622-3002
Henley, Benjamin
Pulgar, Marian A. http://orcid.org/0009-0007-8191-200X
Lehman, Stacey L. http://orcid.org/0000-0001-7029-4719
Gupta, Himanshu
Perez-Vale, Kia Z. http://orcid.org/0000-0003-2262-1679
Weindorfer, Megan http://orcid.org/0009-0002-9993-3427
Vijayaraghavan, Smruthi
Yao, Tsun-Wen Sheena
Laquerre, Sylvie
Moores, Sheri L.
- License Information
-
More Information
Article History
Received: 19 January 2024
Accepted: 28 August 2024
First Online: 6 September 2024
Competing interests
: R.R.S., B.H., S.L., H.G., M.W., S.V., T.S.Y. are current employees of Johnson & Johnson but declare no non-financial competing interests. S.L. and S.M. are former employees of Johnson & Johnson but declare no non-financial competing interests. MP and KPV declare no competing interests. S.M. and B.H. reports a patent application for US17/687,984 - Treatment of Cancers Lacking EGFR- Activating Mutations, pending. S.M reports a patent US9593164B2 - bispecific EGFR/Met antibodies, issued.
